543520

Global Longlife Hospital and Research Share Price

 

 

Start SIP in 543520

Start SIP

Performance

  • Low
  • ₹13
  • High
  • ₹14
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹33
  • Open Price₹14
  • Previous Close₹13
  • Volume113,000
  • 50 DMA₹18.53
  • 100 DMA₹20.90
  • 200 DMA₹24.38

Investment Returns

  • Over 1 Month -34.66%
  • Over 3 Month -42.3%
  • Over 6 Month -38.38%
  • Over 1 Year -53.84%

Smart Investing Starts Here Start SIP with Global Longlife Hospital and Research for Steady Growth!

Invest Now

Global Longlife Hospital and Research Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 74.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 15
  • P/B Ratio
  • 0.6
  • Average True Range
  • 0.99
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.07
  • RSI
  • 35.01
  • MFI
  • 37.7

Global Longlife Hospital and Research Financials

Global Longlife Hospital and Research Technicals

EMA & SMA

Current Price
₹14.08
+ 0.67 (5%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹15.62
  • 50 Day
  • ₹18.53
  • 100 Day
  • ₹20.90
  • 200 Day
  • ₹24.38

Resistance and Support

13.87 Pivot Speed
  • R3 14.93
  • R2 14.51
  • R1 14.29
  • S1 13.65
  • S2 13.23
  • S3 13.01

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Global Longlife Hospital And Research has an operating revenue of Rs. 14.09 Cr. on a trailing 12-month basis. An annual revenue de-growth of -59% needs improvement, Pre-tax margin of 17% is great, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Global Longlife Hospital and Research Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Half Yearly Results
2025-04-28 Audited Results
2024-10-28 Half Yearly Results
2024-05-20 Audited Results
2023-11-11 Half Yearly Results

Global Longlife Hospital and Research F&O

Global Longlife Hospital and Research Shareholding Pattern

35.44%
53.48%
11.08%

About Global Longlife Hospital and Research

  • NSE Symbol
  • 543520
  • BSE Symbol
  • 543520
  • Managing Director
  • Mr. Dhruv Jani
  • ISIN
  • INE0J2K01014

Similar Stocks to Global Longlife Hospital and Research

Global Longlife Hospital and Research FAQs

Global Longlife Hospital and Research share price is ₹14 As on 16 February, 2026 | 17:43

The Market Cap of Global Longlife Hospital and Research is ₹14.8 Cr As on 16 February, 2026 | 17:43

The P/E ratio of Global Longlife Hospital and Research is 74.4 As on 16 February, 2026 | 17:43

The PB ratio of Global Longlife Hospital and Research is 0.6 As on 16 February, 2026 | 17:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23